Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Cancer Research and Treatment is Scopus-indexed (Q1, CiteScore 7.7), WoS SCIE. Published by Korean Cancer Association.
Checked against the index lists dated .
ISSN 1598-2998Verify ISSN ↗2005-9256Verify ISSN ↗
Publisher: Korean Cancer Association
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 77 / 428 | 82nd | Q1 |
| Cancer Research | 67 / 233 | 71st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2011–present (also 2001), best quartile Q1, CiteScore 7.7.
Cancer Research and Treatment is Q1 in Oncology (rank 77 of 428) and Q2 in Cancer Research (rank 67 of 233), by CiteScore 2025.
Cancer Research and Treatment is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 7.7, which places it in quartile Q1 at the 82nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.462, quartile Q1, with an H-index of 68.
Cancer Research and Treatment is published by Korean Cancer Association. Its print ISSN is 1598-2998 and its online ISSN is 2005-9256.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal per Scopus.
Cancer Research and Treatment has an h-index of 85 and a 2-year mean of 3.24 citations per paper (OpenAlex). Its Scopus CiteScore is 7.7, quartile Q1. On 2-year citations it ranks #100 of 424 Scopus journals in Oncology.
Cancer Research and Treatment published 164 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2025–2026), authors are most often from South Korea (70.1%), China (16.6%) and United States (4.9%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 11 retracted papers are recorded (4.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.